Caring Brands (CABR) Non-Current Assets (2024 - 2025)
Caring Brands (CABR) posted quarterly Non-Current Assets of $3.1 million for Q3 2025, down 6.72% quarter-over-quarter from $3.4 million in Q4 2024.
Caring Brands (CABR) Non-Current Assets (2024 - 2025) Analysis & Trends
Caring Brands' Non-Current Assets history runs 2 years deep, the most recent figure standing at $3.1 million for Q3 2025.
- In Q3 2025, Non-Current Assets changed N/A year-over-year to $3.1 million; the TTM figure through Dec 2024 stood at $3.4 million (changed N/A YoY), while the FY2024 annual figure was $3.4 million, changed N/A from the prior year.
- Non-Current Assets for Q3 2025 stood at $3.1 million, down from $3.4 million in the prior quarter.
- The five-year high for Non-Current Assets was $3.4 million in Q4 2024, with the low at $3.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.96 Bn |
| 10 | Caring Brands | 11.69 Mn | 9.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.13 Mn |
| Dec 31, 2024 | 3.35 Mn |